pyridostigmine bromide has been researched along with amyloid beta-peptides in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adani, R; Amitai, G; Avila, J; Farías, GG; Godoy, JA; Inestrosa, NC; Meshulam, H; Vázquez, MC | 1 |
1 other study(ies) available for pyridostigmine bromide and amyloid beta-peptides
Article | Year |
---|---|
The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Brain; Cells, Cultured; Cholinesterase Inhibitors; Cytoskeletal Proteins; Disease Models, Animal; Down-Regulation; Drug Compounding; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Ibuprofen; Intercellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Neuroprotective Agents; Peptide Fragments; Pyridinium Compounds; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Signal Transduction; Trans-Activators; Wnt Proteins | 2005 |